SCHEMBL27040488

SCHEMBL27040488

CN(C)c1ccc2c(S(=O)(=O)Cl)cccc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NCF1 P14598 1/20 0.46
▸ C1R P00736 3/20 0.36
▸ PRSS1 P07477 2/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ S1PR1 P21453 1/20 0.35
▸ OPRD1 P41143 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ KDM1A O60341 1/20 0.35
▸ CA2 P00918 1/20 0.34
▸ TXNRD1 Q16881 1/20 0.34
▸ ALDH1A1 P00352 4/20 0.33
▸ HSD17B10 Q99714 3/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ GLA P06280 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ GAA P10253 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27040312 0.79 ALDH1A1 (0.49) NCF1C1RPRSS1POLBALDH1A1
SCHEMBL27040972 0.77 P2RX7 (0.40) ADORA2AADORA1ALDH1A1HSD17B10KDM4E
SCHEMBL9780245 0.74 ALDH1A1 (0.41) C1RPRSS1POLBCA2ALDH1A1
SCHEMBL27041076 0.72 TRPV4 (0.38) POLBALDH1A1HSD17B10TDP1
SCHEMBL27040551 0.71 BACE1 (0.55) NCF1C1RADORA2AADORA1S1PR1
SCHEMBL27051422 0.71 NCF1 (0.49) NCF1ADORA2AADORA1S1PR1OPRD1
SCHEMBL3685348 0.70 NSD2 (0.40) CA2ALDH1A1HSD17B10KDM4ETDP1
SCHEMBL30879534 0.70 NSD2 (0.40) CA2ALDH1A1HSD17B10KDM4ETDP1
SCHEMBL1051623 0.69 ALDH1A1 (0.51) POLBCA2ALDH1A1HSD17B10KDM4E
SCHEMBL9762545 0.69 ALDH1A1 (0.65) NCF1ADORA2APOLBTXNRD1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260027104-A1 NOVEL NAPHTHYL AND ISOQUINOLINE SULFONAMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2026-01-29 — — US disclosed
EP-4558479-A1 NOVEL NAPHTHYL AND ISOQUINOLINE SULFONAMIDE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2025-05-28 — — EP disclosed
CN-119546572-A Novel naphthyl and isoquinoline sulfonamide derivatives 豪夫迈·罗氏有限公司 2025-02-28 — — CN disclosed
WO-2024017858-A1 NOVEL NAPHTHYL AND ISOQUINOLINE SULFONAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2024-01-25 — — WO disclosed
WO-2024017858-A1 NOVEL NAPHTHYL AND ISOQUINOLINE SULFONAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2024-01-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260027104-A1 NOVEL NAPHTHYL AND ISOQUINOLINE SULFONAMIDE DERIVATIVES CBR3, HAX1, CBR1 NCF1 1316/4885C1R 1402/4885PRSS1 4688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback